Fate Therapeutics Inc (FATE)

Aug 12, 2025

Bullish Divergence Spotted in Fate Therapeutics Inc. MomentumAccurate Buy Point for Momentum Stocks Detected - 선데이타임즈

Aug 12, 2025

Aug 12, 2025

Fate Therapeutics earnings beat by $0.05, revenue topped estimates - Investing.com Canada

Aug 12, 2025

Aug 12, 2025

Fate Therapeutics: Q2 Earnings Snapshot - San Francisco Chronicle

Aug 12, 2025

Aug 12, 2025

Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Aug 12, 2025

Aug 12, 2025

Fate Therapeutics Announces Corporate Restructuring Plan - TipRanks

Aug 12, 2025

Aug 12, 2025

Fate Therapeutics' Q2 2025 Earnings: A Strategic Catalyst for Long-Term Shareholder Value - AInvest

Aug 12, 2025

Aug 12, 2025

Fate Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2025

Aug 12, 2025

Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Aug 12, 2025

Aug 09, 2025

Can machine learning forecast Fate Therapeutics Inc. recoveryBuy Opportunity Forecast for Fast Traders - Newser

Aug 09, 2025

Aug 08, 2025

What makes Fate Therapeutics Inc. stock price move sharplyHigh Conviction Stock Long-Term Summary - Newser

Aug 08, 2025

Aug 08, 2025

Why Fate Therapeutics Inc. stock attracts strong analyst attentionFree Real Time Trade Opportunity Alerts - Newser

Aug 08, 2025

Aug 08, 2025

Analyzing net buyer seller activity in Fate Therapeutics Inc.Free Entry and Exit Strategy Optimizer Tool - Newser

Aug 08, 2025

Aug 08, 2025

Fate Therapeutics Inc. stock trend forecastFree Risk Controlled Picks With Real Returns - Newser

Aug 08, 2025

Aug 08, 2025

Fate Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 07, 2025

Trapped Investors in Fate Therapeutics Inc. Await Breakout SignalWatchlist for Smart Swing Trading Updated - metal.it

Aug 07, 2025

Aug 07, 2025

Fate Therapeutics shares fall 4.52% intraday due to unspecified reasons. - AInvest

Aug 07, 2025

Aug 06, 2025

Full technical analysis of Fate Therapeutics Inc. stockSwing Trade Picks with High Potential - Newser

Aug 06, 2025

Aug 06, 2025

Fate Therapeutics shares fall 4.17% intraday after granting non-qualified stock options to a new employee. - AInvest

Aug 06, 2025

Aug 05, 2025

Fate Therapeutics CEO Makes a Notable Stock Sale! - TipRanks

Aug 05, 2025

Aug 05, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Aug 05, 2025

Aug 05, 2025

Fate Therapeutics' Strategic Talent Acquisition and Equity Incentive Program: A Catalyst for Biotech Innovation and Shareholder Value - AInvest

Aug 05, 2025

Aug 05, 2025

Fate Therapeutics reports new employee inducement awards - MarketScreener

Aug 05, 2025

Aug 05, 2025

Fate Therapeutics CEO Valamehr sells $15,396 in stock By Investing.com - Investing.com Canada

Aug 05, 2025

Aug 05, 2025

Fate Therapeutics CEO Valamehr sells $15,396 in stock - Investing.com

Aug 05, 2025

Aug 05, 2025

Cwm LLC Buys 37,290 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

Aug 05, 2025

Aug 05, 2025

Fate Therapeutics (NASDAQ:FATE) Upgraded at Wall Street Zen - Defense World

Aug 05, 2025

Aug 04, 2025

Fate Therapeutics Inc. Nearing Breakout Level After BounceAccurate Technical Trend Reversal Picks Detected - metal.it

Aug 04, 2025

Aug 03, 2025

What catalysts could drive Fate Therapeutics Inc. stock higher in 2025Capitalize on trading strategies that deliver - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Fate Therapeutics Inc. stockFree Stock Market Return Analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Fate Therapeutics Inc. company’s balance sheetFree Capital Efficiency Planning - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Fate Therapeutics Inc. generate profit in a changing economyFree Stock Market Trend Analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Wells Fargo Maintains Fate Therapeutics(FATE.US) With Hold Rating, Maintains Target Price $4 - 富途牛牛

Aug 03, 2025

Aug 03, 2025

What is Fate Therapeutics Inc. company’s growth strategyUnlock exclusive stock market insights - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What are Fate Therapeutics Inc. company’s key revenue driversUnlock powerful trading signals and alerts - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How does Fate Therapeutics Inc. compare to its industry peersBuild a diversified portfolio for risk mitigation - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Does Fate Therapeutics Inc. stock perform well during market downturnsMassive stock growth - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is Fate Therapeutics Inc. a growth stock or a value stockInvest confidently with market-leading analysis - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Fate Therapeutics’ Phase 1 Study: A New Hope for Autoimmune Diseases - TipRanks

Aug 01, 2025

Jul 31, 2025

How volatile is Fate Therapeutics Inc. stock compared to the marketTop Growth Tracker With Low Risk - Jammu Links News

Jul 31, 2025

Jul 30, 2025

Published on: 2025-07-30 19:50:13 - metal.it

Jul 30, 2025

Jul 30, 2025

Published on: 2025-07-30 17:10:31 - beatles.ru

Jul 30, 2025

Jul 30, 2025

Published on: 2025-07-30 08:12:45 - metal.it

Jul 30, 2025

Jul 29, 2025

How Resilient Is Fate Therapeutics Inc. Stock During Economic DownturnsDaily Smart Money Movement Monitor Activated - metal.it

Jul 29, 2025

Jul 29, 2025

Will Fate Therapeutics Inc. stock go up soonShort-Term Swing Opportunity Summary Sheet - Newser

Jul 29, 2025

Jul 29, 2025

What to expect from Fate Therapeutics Inc. in the next 30 daysFree AI Powered High Return Stock Calls - Newser

Jul 29, 2025

Jul 28, 2025

Ranking Fate Therapeutics Inc. among high performing stocks via toolsWeekly Gain Forecast with Momentum Indicators - Newser

Jul 28, 2025

Jul 28, 2025

Can Fate Therapeutics Inc. stock recover from recent declineLong Term Safe Yield Focus - metal.it

Jul 28, 2025